immediate implant using nanobone versus autogenous bone for treatment of patients with unrestorable single tooth.

evaluation of surgical time, post-operative pain and marginal bone loss in immediate implant using "nanobone" versus "autogenous bone" for treatment of patients with unrestorable single tooth.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201512001348246

Enrollment

Registered

2015-11-15

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Unrestorable single tooth, fracture tooth in esthetic zone

Interventions

nanobone graft

autogenous bone graft

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients suffering from unrestorable tooth. Good oral hygiene. Candidate for classical implant placement. Patients should be free from any systemic disease that may affect normal healing of bone, and predictable outcome.

Exclusion criteria

Exclusion criteria: Patients with severely atrophic ridges requiring a staged grafting procedure. Intra oral soft tissue defect that would affect the closure of the intra oral wound. Patients with any systemic disease that may affect normal healing. Patient with bad oral hygiene.

Design outcomes

Primary

Measure	Time frame
Surgical pain;Intra operative time .	—

Secondary

Measure	Time frame
Marginal bone loss	—

Countries

Egypt

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026